Cite
HARVARD Citation
Koch-Henriksen, N. (2021). It is safe to switch therapy from interferon beta or glatiramer acetate to oral therapy in patients with relapsing multiple sclerosis with stable disease. Journal of neurology, neurosurgery and psychiatry. 92 (5), p. 457. [Online].